Publications by authors named "Guobin Fu"

Claim this Profile
S
Serum zinc as a biomarker to predict the efficacy of immune checkpoint inhibitors in cancers.
Jingliang Wang, Weihao Wang, Bin Liu, Rui Zhao, Jing Zhao, Guobin Fu

PLoS One· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLK1 in cancer therapy: a comprehensive review of immunomodulatory mechanisms and therapeutic opportunities.
Weihao Wang, Rui Zhao, Yahui Wang, Liying Pan, Fang Luan, Guobin Fu

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Safety of COVID-19 Vaccines in Patients with Lung Cancer: Results of a Systematic Review and Meta-Analysis.
Zhizhao Zhang, Yahui Wang, Jing Zhao, Lei Liu, Pancen Ran, Guobin Fu

Int Arch Allergy Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High level of anti-drug antibodies is associated with shorter survival in advanced solid cancer patients treated with Immune checkpoint inhibitors.
Rui Zhao, Weihao Wang, Jingliang Wang, Yahui Wang, Liying Pan, Guobin Fu

Immunother Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polysaccharide from Atractylodes macrocephala Koidz. alleviates pyrotinib-induced diarrhea through regulating cAMP/LKB1/AMPK/CFTR pathway and restoring gut microbiota and metabolites.
Pancen Ran, Fengxian Jiang, Liying Pan, Yang Shu, Fangyan Hu, Guobin Fu

Int J Biol Macromol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of Atractylenolide Ⅲ alleviating pyrotinib-induced diarrhea by regulating AMPK/CFTR pathway through metabolite of gut microbiota.
Fengxian Jiang, Pancen Ran, Liyin Pan, Jingjiang Lai, Junlei Zhang, Guobin Fu

J Tradit Complement Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Serum iron element: A novel biomarker for predicting PD-1 immunotherapy efficacy" [Int. Immunopharmacol. 131 (2024) 111823].
Fang Luan, Jingliang Wang, Lei Liu, Bin Liu, Fuxia Li, Guobin Fu

Int Immunopharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis.
Rui Zhao, Yang Shu, Wei Xu, Fengxian Jiang, Pancen Ran, Guobin Fu

Cancer Cell Int· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum iron element: A novel biomarker for predicting PD-1 immunotherapy efficacy.
Fang Luan, Jingliang Wang, Lei Liu, Bin Liu, Fuxia Li, Guobin Fu

Int Immunopharmacol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival and safety analysis of COVID-19 vaccine in Chinese patients with non-small cell lung cancer.
Wei Xu, Jing Zhao, Fang Luan, Zhizhao Zhang, Lei Liu, Guobin Fu

Cancer Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isotopic evidence for soil water sources and reciprocal movement in a semi-arid degraded wetland: Implications for wetland restoration.
Yuanchun Zou, Sijian Zhang, Xiaofei Yu, Guobin Fu, Xianguo Lu

Fundam Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-positive breast cancer progresses rapidly after pyrotinib resistance: acquired RET gene fusion and TP53 gene mutation are potential reasons.
Fengxian Jiang, Jingjiang Lai, Xiaoli Zhuo, Lei Liu, Yucheng Yang, Guobin Fu

Anticancer Drugs· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the potential for groundwater-related ground deformation in Southern New South Wales, Australia.
Pascal Castellazzi, Wolfgang Schmid, Guobin Fu

Sci Total Environ· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical applications of radiomics in non-small cell lung cancer patients with immune checkpoint inhibitor-related pneumonitis.
Yang Shu, Wei Xu, Rui Su, Pancen Ran, Lei Liu, Guobin Fu

Front Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential mechanism of pyrotinib-induced diarrhea was explored by gut microbiome and ileum metabolomics.
Jingjiang Lai, Xiaoli Zhuo, Ke Yin, Fengxian Jiang, Lei Liu, Guobin Fu

Anticancer Drugs· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptation to climate change through strategic integration of long fallow into cropping system in a dryland Mediterranean-type environment.
Chao Chen, Noboru Ota, Bin Wang, Guobin Fu, Andrew Fletcher

Sci Total Environ· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having HER2 alterations.
Xiaoli Zhuo, Honglin Guo, Jun Ma, Jingjiang Lai, Lei Liu, Guobin Fu

J Cancer Res Clin Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Pralsetinib in Multi-Drug-Resistant Breast Cancer With CCDC6-RET Mutation.
Jing Zhao, Wei Xu, Xiaoli Zhuo, Lei Liu, Junlei Zhang, Guobin Fu

Oncologist· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Real-world Therapeutic Analysis of First-line Immunotherapy in Chinese Patients with Drive Gene Positive for Advanced Non-Small Cell Lung Cancer.
Lei Liu, Fuxia Li, Jing Zhao, Xiaoli Zhuo, Jingjiang Lai, Guobin Fu

J Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The allelic regulation of tumor suppressor ADARB2 in papillary thyroid carcinoma.
Wenwen Li, Teng Wang, Guobin Fu, Yuan Xu, Nasha Zhang

Endocr Relat Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Shenling Baizhu powder on pyrotinib-induced diarrhea: analysis of gut microbiota, metabonomics, and network pharmacology.
Jingjiang Lai, Fengxian Jiang, Xiaoli Zhuo, Xiaoying Xu, Lei Liu, Guobin Fu

Chin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and challenges of immune checkpoint inhibitors for extensive-stage small-cell lung cancer.
Jing Zhao, Xiaoli Zhuo, Lei Liu, Zhe Yang, Guobin Fu

Cancer Innov· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surface Water-Groundwater Interaction in the Guanzhong Section of the Weihe River Basin, China.
Feihe Kong, Jinxi Song, Yan Zhang, Guobin Fu, Dandong Cheng

Ground Water· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study.
Haimin Lin, Dali Han, Guobin Fu, Chengxin Liu, Lili Wang

Onco Targets Ther· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.
Jue Wang, Hongchang Shen, Guobin Fu, Dandan Zhao, Weibo Wang

Oncotarget· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis